Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

BioAtla (BCAB) FCF Margin (2020 - 2025)

BioAtla's FCF Margin history spans 4 years, with the latest figure at 395.75% for Q4 2025.

  • For Q4 2025, FCF Margin changed N/A year-over-year to 395.75%; the TTM value through Dec 2025 reached 2410.2%, down 175624.0%, while the annual FY2025 figure was 2410.2%, 175624.0% down from the prior year.
  • FCF Margin reached 395.75% in Q4 2025 per BCAB's latest filing, down from 46.65% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 46.65% in Q3 2024 to a low of 5405.2% in Q2 2021.
  • Average FCF Margin over 3 years is 1949.2%, with a median of 395.75% recorded in 2025.
  • The largest YoY upside for FCF Margin was -383520bps in 2021 against a maximum downside of -383520bps in 2021.
  • A 3-year view of FCF Margin shows it stood at 5405.2% in 2021, then surged by 99bps to 46.65% in 2024, then tumbled by -748bps to 395.75% in 2025.
  • Per Business Quant, the three most recent readings for BCAB's FCF Margin are 395.75% (Q4 2025), 46.65% (Q3 2024), and 5405.2% (Q2 2021).